Open Label Extension Study of HT-100 in Patients With DMD
NCT01978366
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class
Stopped
Dosing stopped
Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG:
HT-100
Sponsor
Processa Pharmaceuticals